BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21504238)

  • 1. Health economic and infectious disease modelling: a guide to merging streams.
    Anonychuk A; Krahn M
    Pharmacoeconomics; 2011 May; 29(5):367-9. PubMed ID: 21504238
    [No Abstract]   [Full Text] [Related]  

  • 2. Modelling the epidemiology of infectious diseases for decision analysis: a primer.
    Jit M; Brisson M
    Pharmacoeconomics; 2011 May; 29(5):371-86. PubMed ID: 21504239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merging economics and epidemiology to improve the prediction and management of infectious disease.
    Perrings C; Castillo-Chavez C; Chowell G; Daszak P; Fenichel EP; Finnoff D; Horan RD; Kilpatrick AM; Kinzig AP; Kuminoff NV; Levin S; Morin B; Smith KF; Springborn M
    Ecohealth; 2014 Dec; 11(4):464-75. PubMed ID: 25233829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease.
    Haeussler K; den Hout AV; Baio G
    BMC Med Res Methodol; 2018 Aug; 18(1):82. PubMed ID: 30068316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review.
    Drake TL; Devine A; Yeung S; Day NP; White LJ; Lubell Y
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):124-39. PubMed ID: 26778620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six challenges in the eradication of infectious diseases.
    Klepac P; Funk S; Hollingsworth TD; Metcalf CJ; Hampson K
    Epidemics; 2015 Mar; 10():97-101. PubMed ID: 25843393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health economics--what the nephrologist should know.
    Palmer AJ
    Nephrol Dial Transplant; 2005 Jun; 20(6):1038-41. PubMed ID: 15840678
    [No Abstract]   [Full Text] [Related]  

  • 8. [Communicable diseases cost money. Difficult but important to provide the costs for society].
    Fredlund H; Giesecke J
    Lakartidningen; 1998 Feb; 95(6):522-6. PubMed ID: 9494355
    [No Abstract]   [Full Text] [Related]  

  • 9. Pricing infectious disease. The economic and health implications of infectious diseases.
    Fonkwo PN
    EMBO Rep; 2008 Jul; 9 Suppl 1(Suppl 1):S13-7. PubMed ID: 18578017
    [No Abstract]   [Full Text] [Related]  

  • 10. The hidden economic benefits of childhood immunizations in Capital Health region, Alberta.
    Can Commun Dis Rep; 2006 Jan; 32(2):18-21. PubMed ID: 16649297
    [No Abstract]   [Full Text] [Related]  

  • 11. Global health, personal action.
    Keusch GT
    Clin Infect Dis; 2004 Mar; 38(6):879-80. PubMed ID: 14999634
    [No Abstract]   [Full Text] [Related]  

  • 12. Simple Inclusion of Complex Diagnostic Algorithms in Infectious Disease Models for Economic Evaluation.
    Dodd PJ; Pennington JJ; Bronner Murrison L; Dowdy DW
    Med Decis Making; 2018 Nov; 38(8):930-941. PubMed ID: 30403578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical issues in the economic evaluation of interventions against communicable diseases.
    Hutubessy RC; Bendib LM; Evans DB
    Acta Trop; 2001 Mar; 78(3):191-206. PubMed ID: 11311183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mathematical modelling of an infectious disease in a prison setting and optimal preventative control strategies].
    Trujillo-Salazar CA; Toro-Zapata HD; Muñoz-Loaiza A
    Rev Salud Publica (Bogota); 2013; 15(6):943-56. PubMed ID: 25124356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of a healthy school environment.
    Rubino JR
    J Sch Nurs; 2002 Oct; Suppl():27-30. PubMed ID: 12387604
    [No Abstract]   [Full Text] [Related]  

  • 16. The economic and social benefits of childhood vaccinations in BRICS.
    Mirelman AJ; Ozawa S; Grewal S
    Bull World Health Organ; 2014 Jun; 92(6):454-6. PubMed ID: 24940021
    [No Abstract]   [Full Text] [Related]  

  • 17. Economic Incentives in the Socially Optimal Management of Infectious Disease: When [Formula: see text] is Not Enough.
    Morin BR; Kinzig AP; Levin SA; Perrings CA
    Ecohealth; 2018 Jun; 15(2):274-289. PubMed ID: 28963686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015.
    Bozorgmehr K; Wahedi K; Noest S; Szecsenyi J; Razum O
    Euro Surveill; 2017 Oct; 22(40):. PubMed ID: 29019315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transfusion-transmitted Infections: How Useful and Costly is Testing for new Infectious Disease Pathogens?].
    Niederhauser C
    Praxis (Bern 1994); 2018 Apr; 107(9-10):521-529. PubMed ID: 29690842
    [No Abstract]   [Full Text] [Related]  

  • 20. A guide to interpreting economic studies in infectious diseases.
    Roberts RR; Mensah EK; Weinstein RA
    Clin Microbiol Infect; 2010 Dec; 16(12):1713-20. PubMed ID: 20825433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.